ARTICLE | Clinical News
Cervarix regulatory update
July 11, 2016 7:00 AM UTC
EMA’s CHMP recommended expanding the label of Cervarix from GlaxoSmithKline to include prevention of premalignant anal lesions and anal cancers causally related to certain oncogenic HPV types in peopl...